The Audit Committee assists the Board in fulfilling its oversight of the quality and integrity of the accounting, auditing, reporting, and financial control practices of the Company. The Audit Committee is responsible to review the Company’s: financial reports; auditing and accounting policies and procedures; internal control systems; material asset or derivatives transactions; material lending funds, endorsements or guarantees; offering or issuance of any equity-type securities; legal compliance; hiring or dismissal of an attesting CPA, etc. TaiMed’s Audit Committee consist of all independent Directors and Professor Ming-Ching Chen serves as the chairman of committee. Please consult TaiMed’s Annual Report for the relevant year for the number of meetings convened and each member’s attendance rate.


Chairman / Ming-Ching Chen, Ph.D.

  • Ph.D. degree in Accounting from Arizona State University, USA
  • Professor, Department of Accounting, National ChengChi University

Member / Howard S. Lee, Ph.D.

  • PhD in Chemistry, University of Southern California, USA
  • Partner, The CID Group
  • Chairman, Easywell Biomedicals, Inc.
  • Chairman, TAHO Pharmceuticals, Ltd.
  • Chairman, Transwell Biotech CO., Ltd.